10 The RCSB Protein Data Bank (PDB) offers online tools, summary reports and target information related to the worldwide structural genomics initiatives from its portal at http://sg.pdb.org. There are currently three components to this site: Structural 15 Genomics Initiatives contains information and links on each structural genomics site, including progress reports, target lists, target status, targets in the PDB and level of sequence redundancy; Targets provides combined target information, protocols and other 20 data associated with protein structure determination; and Structures offers an assessment of the progress of structural genomics based on the functional coverage of the human genome by PDB structures, structural genomics targets and homo-25 logy models. Functional coverage can be examined according to enzyme classification, gene ontology (biological process, cell component and molecular function) and disease.
INTRODUCTION 30 The wwPDB (1) maintains the Protein Data Bank (PDB) archives of biological macromolecular structure data, currently comprising over 32 500 structures. Since the year 2000, the worldwide structural genomics initiatives have provided more than 2400 structures, which have also added a 35 large number of new folds. To represent the progress of this collective effort, the RCSB PDB (2) has developed and maintains the Structural Genomics Information Portal at http://sg.pdb.org which consists of three main sections, outlined below.
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Structural genomics initiatives
The first section of the information portal provides summary information about each structural genomics center, including target lists, target status, targets in the PDB and sequence redundancy analyses. Summary statistics describing the over- 45 all progress of all contributing projects, including sequence similarity and number of structures determined, are regularly tabulated. As an example, an analysis of the sequence similarity of structures solved by structural genomics projects relative to structures in the PDB archive is shown in Figure 1 .
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Targets
The Targets section offers databases that track target registration data. Currently, 20 structural genomics centers contribute data to the TargetDB ( in the protein production pipeline. PepcDB captures a complete history of the experimental steps in each production trial, in addition to describing the current target production status. The status history in PepcDB also records the time interval 5 required to complete each experimental step, with an explanation if work on a particular target or experiment was terminated. Standard protocol descriptions are collected in text form for each step of protein production. Multiple experimental trials can be described for each target. Each trial may reference 10 a set of standard protocols and optionally include the special details of an experimental step and the experimentally observed sequence. A validation server has been provided for PepcDB contributors (http://pepcdb.pdb.org/validation.html). Data files 15 validated through this form are automatically loaded into the PepcDB database. PepcDB currently includes protocol information from the NIH Protein Structure Initiative (PSI) centers. TargetDB status data from all other structural genomics centers are merged into PepcDB. As a result, PepcDB 20 always provides the most complete view of target status and experimental information for structural genomics projects. The search features of PepcDB build upon those of TargetDB by offering additional tools to mine experimental protocols. Protocol searches are integrated with queries for 25 target sequence and other target attributes. The resulting report includes the essential target description provided by TargetDB plus additional links to a chronological status history and links to related experimental protocols. Markov models taken from SUPERFAMILY 1.65. The sequences were aligned to the structural template with HMMER (9). Only those assigned domains with sequence identity >30% in the alignment were considered as homology models.
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Through the functional distribution site, this question can be addressed by examining molecular function, biological process and cellular component [as assigned by the Gene Ontology, GO (10)], enzymes via their EC numbers (www. chem.qmw.ac.uk/iubmb/enzyme), and diseases assigned through OMIM (7) . Several steps are used to define the search parameters; here molecular function is used as an example. In Step 1 (Molecular Function) the breadth of the search is defined, which in turn defines the details presented in the results. So, for example, the top level of the GO hierarchy for molecular function is displayed and used by default. All 5 structures could be selected, or a subgroup could be selected (e.g. all structures with the molecular function 'vitamin binding') by browsing through the hierarchical tree. Similarly in
Step 2 (Structure Type), all structures are chosen by default, but it is possible to drill down and explore just groups of 10 structures based on the SCOP classification of class (all alpha, all beta, etc.) (11) .
Step 3 selects the genome. At present only the human genome is available, but other model organisms will be added.
Step 4 selects the sequence identity to use, with 40% identity the default. Sequence identity defines 15 how the human genome sequences are clustered and a single function assigned for that cluster-at lower sequence identity there are fewer clusters, i.e. the results are effectively at lower resolution.
Step 5 specifies the domain combinations needed for a match. Since PDB structures frequently represent a 20 single domain in a larger complex, statistics can be produced requiring overlap for one or more domains up to the whole structure accounting for domain rearrangements [see (5) for a full description].
Based on these input parameters, one of three distributions 25 can be generated: a comparison of the distribution of PDB structures, structure genomics targets or homology models against the human genome; a 'most wanted list' Data are based upon 10 801 functionally described human genome sequences from Ensembl, 942 PDB structures from human, 1680 structural genomics targets identified in human and 2823 homology models from SUPERFAMILY mapped on to the human genome. Cluster Coverage is the ratio of number of protein clusters that are structurally covered versus all clusters in the genome for a functional class with a specified sequence identity (40% in this case). Functional class and sequence identity are input parameters. t r a n s c r i p t i o n r e g u l a t o r a c t i v i t y t r a n s l a t i o n r e g u l a t o r a c t i v i t y t r a n s p o r t e r a c t i v i t y 
Molecular Function
Human Genome PDB Structural Genomics Targets Homology Models Figure 2 . Normalized functional coverage of the human genome by sequence (from Ensembl; red), by structures from the PDB (blue), by structural genomics targets (green) and homology models from SUPERFAMILY (yellow). When viewing the figure from the online structural genomics portal, clicking on the appropriate bar of the histogram will produce a list of sequences or structures that define the distribution.
of structures-those not in the PDB and which (by default) are not identified through homology modeling or in the structural genomics targets yet have significant presence in the human genome; and simple charts showing the distribution of the 5 genome sequences, PDB structures, structural genomics targets or homology models. Most distributions are accompanied by two tables illustrating, first, the functional coverage by each data type (Table 1) , and second, the correlation between input data types (data not shown). The actual overlap between these 10 groups will be added as part of an on-going development. For example in Table 1 , PDB structures cover 37.2% of the identified molecular functions in the human genome; if solved, structural genomics targets cover 32.4% of functions; and 56.3% of the molecular functions can be modeled from exist-15 ing structures. Figure 2 illustrates the resulting normalized distributions for the top level of the GO molecular function hierarchy. At this level most distributions are not skewed with the exception of molecular function unknown-PDB structures are underrepresented and structural genomics targets 20 are overrepresented. Not surprising, since until structural genomics began structural biology was dominated by determining structures of known function. In the era of structural genomics, that trend has reversed. Drilling down to more detailed descriptions of molecular function (data not shown) 25 reveals a more uneven distribution and suggests changes in structure determination strategies. An important feature of this resource is the 'most wanted list' of structures based on the following criteria: (i) functional categories where proteins are underrepresented by structures; 30 (ii) from (i), proteins which can not be modeled, i.e. proteins from the human genome without SUPERFAMILY assignments; (iii) if the protein can be associated with a human disease; and (iv) proteins identified as likely to be intractable, i.e. with a transmembrane segment filtered out.
CONCLUSION
In this report, we present the resources currently made available through the RCSB PDB in support of the structural genomics effort. It is expected that further functionality will be added as the second phase of the PSI and other worldwide 40 efforts move forward.
